Online clinical trials hold promise for research but scientists should think hard before using them in poorer countries, says Priya Shetty.

Quack science and illogical claims abound in Pakistan, says Pervez Hoodbhoy.

Some Muslim countries' powerful financial incentives to make quick progress in research could backfire, cautions Athar Osama.

Developing countries forging ahead with nanotechnology need regulation and research into local risk patterns, say Alok Dhawan and Vyom Sharma.

Scientists must collaborate with indigenous communities to rebuild trust and ensure shared benefits, says geneticist Vanessa M. Hayes.

The current practice of keeping complexity out of scientific advice is misguided, inviting over-confidence and error, argues Andy Stirling.

A Nature editorial calls on the global academic community to support investigations into allegations of scientific plagiarism in Iran.

Countries should measure themselves against a set of standards to assess the integrity of their research bases, says a Nature editorial.

Disaster research can help future interventions, but urgency should never excuse exploitation of survivors, says Athula Sumathipala.

For its own international credibility, Indian science must be seen to deal with scientific misconduct, says N. Raghuram.

Public-private partnership organisations have failed to include African researchers on an equal basis, say T. J. Tucker and M. W. Makgoba.

Africa should develop its own ethical review systems, not copy foreign arrangements, say Carl H. Coleman and Marie-Charlotte Bouësseau.

Jon Cohen says extreme distrust of pharmaceutical companies detracts attention from legitimate ethical questions about clinical research.

By giving bioethics a human face, UNESCO's much-maligned Universal Declaration on Bioethics is a triumph for the developing world, says Mônica C. Serra.

Robert Grant and colleagues say that despite controversy surrounding trials of promising HIV preventive drugs, we must encourage such research rather than try to curb it.

UNESCO's declaration on bioethics and human rights is too weak to be of value, and could harm the world's poor if developing countries accept it, says Richard Ashcroft.

Researchers running clinical trials in developing countries should focus more on ethics and worry less about the incentives offered to potential participants, say Ezekiel Emanuel and colleagues.

Understanding science and its implications is a human right, argues Xiong Lei, in this perspective from China.

Treating research participants from vulnerable populations ethically means more than considering drugs' potential side-effects; researchers must also frame their work within a human rights context, argues Bebe Loff.